When activist investors take a stake in a pharmaceutical company, markets often cheer. The expectation is leaner operations, sharper strategy and higher stock prices.
Pharma ETF FTXH hits a new 52-week high as industry momentum, rate cuts, and AI adoption lift the sector???signaling potential near-term upside for FTXH investors.
Many pharma bigwigs reported solid results, with some beating on earnings or revenues or both.
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.